SEC Filing Update: #LXEO Lexeo Therapeutics, Inc. : $4.84

Sector: Healthcare | YTD: 🔽 -49.69% The SEC disclosed Today (14-AUG-2026) that ORBIMED ADVISORS LLC has DECREASED #LXEO Shares by -18.87% 🔴 BALYASNY ASSET MANAGEMENT LLC also reported an increase in its holdings on the same day. * Previous Holdings: 3.95M Shares * Current Holdings: 3.20M Shares * Decrease -744.80K * Decreased (%)-18.87% * Ownership: 4.1% https://www.thinksabio.com/reports/isr/LXEO Institutional ownership in #LXEO has been steadily rising over the past 5 quarters in Shares: Q1 2025: 28.01M Q2 2025: 42.27M Q3 2025: 49.36M Q4 2025: 76.46M Q1 2026: 79.89M 📌 Institutional activity in the last 30 days for #LXEO: • STATE STREET CORP – Increased holdings by 786,533 shares (07-AUG-2026) • AFFINITY ASSET ADVISORS, LLC – Increased holdings by 867,302 shares (13-AUG-2026) • BALYASNY ASSET MANAGEMENT LLC – Increased holdings by 668,167 shares (14-AUG-2026)